期刊
ADVANCED HEALTHCARE MATERIALS
卷 8, 期 7, 页码 -出版社
WILEY
DOI: 10.1002/adhm.201801501
关键词
3D-bioprinting; articular cartilage tissue engineering; extracellular matrix bioinks; growth factor; polycaprolactone
资金
- European Research Council [ERC-CoG-2014-647004]
- Science Foundation Ireland [12/IA/1554]
- Science Foundation Ireland (SFI) [12/IA/1554] Funding Source: Science Foundation Ireland (SFI)
Focal articular cartilage (AC) defects, if left untreated, can lead to debilitating diseases such as osteoarthritis. While several tissue engineering strategies have been developed to promote cartilage regeneration, it is still challenging to generate functional AC capable of sustaining high load-bearing environments. Here, a new class of cartilage extracellular matrix (cECM)-functionalized alginate bioink is developed for the bioprinting of cartilaginous tissues. The bioinks are 3D-printable, support mesenchymal stem cell (MSC) viability postprinting and robust chondrogenesis in vitro, with the highest levels of COLLII and ACAN expression observed in bioinks containing the highest concentration of cECM. Enhanced chondrogenesis in cECM-functionalized bioinks is also associated with progression along an endochondral-like pathway, as evident by increases in RUNX2 expression and calcium deposition in vitro. The bioinks loaded with MSCs and TGF-3 are also found capable of supporting robust chondrogenesis, opening the possibility of using such bioinks for direct print-and-implant cartilage repair strategies. Finally, it is demonstrated that networks of 3D-printed polycaprolactone fibers with compressive modulus comparable to native AC can be used to mechanically reinforce these bioinks, with no loss in cell viability. It is envisioned that combinations of such biomaterials can be used in multiple-tool biofabrication strategies for the bioprinting of biomimetic cartilaginous implants.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据